Mouse Anti-Levofloxacin Monoclonal antibody, clone L01

Antibody Isotype

IgG

Clone

L01

Conjugate

Application Notes

Suitable for use in ELISA.
Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.

General Notes

This product (Catalog No. CABT-L1607W) is a mouse-derived monoclonal antibody. This antibody exhibits cross-reactivity with from n/a. It has been affinity purified by Protein A. Levofloxacin is a synthetic broad-spectrum fluoroquinolone antibiotic of the third-generation quinolone class, primarily used to treat bacterial infections by inhibiting bacterial DNA replication. It is the pure levo-(S)-enantiomer of the racemic drug ofloxacin, with the chemical formula C₁₈H₂₀FN₃O₄, and exhibits enhanced potency compared to its parent compound due to its stereospecific activity. Developed by Daiichi Sankyo and patented in 1987, levofloxacin received initial FDA approval in 1996 under the brand name Levaquin for oral and intravenous administration.
CABT-L1607W is suitable for use in ELISA application.
CABT-L1607W is supplied as a liquid formulation in PBS. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.

Alternative Names

Levofloxacin